My Elective in Lymphoma & Myeloma at MD Anderson Cancer Center, Houston, Texas

— Shraddha Sriraman

I’m a final year medical student at Bristol with a long-standing interest in oncology and research, especially how lab science actually makes it into real patient care. I came across the MD Anderson elective through a mix of online searching, talking to academic clinicians, and a bit of brave emailing. When I realised they welcomed visiting students into such a research-heavy, clinical environment, I knew I had to apply.

What I actually did at MD Anderson?

My 4 week observership was based in the lymphoma and myeloma service, which meant I was exposed to both incredibly complex blood cancers and some of the most advanced cancer care in the world. I spent time in clinics, MDTs, wards, (had a lab tour!) and got to see how patients move between standard treatments and clinical trials in real life.

One of the things that struck me most was how normal everything felt  - despite the fact that patients were receiving therapies that had only recently been invented. Targeted treatments, immunotherapies, phase 1 trials… these weren’t abstract concepts from a textbook, they were what people were getting that morning in clinic.

What it taught me about oncology?

Oncology is not just about drugs - it’s about trust. Many patients are being asked to join trials that might help them, but might not. Seeing how carefully consultants explained risks, benefits, and uncertainty was powerful. It made me realise how important communication and empathy are in this specialty, especially when you’re dealing with experimental treatments.

It also showed me that oncology is incredibly hopeful. The personalised medicine approach I saw - matching therapies to mutations, immune markers, and tumour profiles - genuinely feels like the future of medicine.

Advice for other medical students

If you’re even slightly curious about oncology, my biggest advice is: go and see it properly. An elective like this shows you the reality behind the lectures: the uncertainty, the teamwork, and the impact of research on people’s lives.

This elective has been one of the highlights of medical school for me. I’m heading back to Bristol with a renewed motivation to combine patient-centred care with science - and hopefully one day, I’ll be part of the next generation of oncologists pushing the field forward.